BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Actelion Pharmaceuticals US, Inc. 

5000 Shoreline Court
Suite 200
South San Francisco  California  94080  U.S.A.
Phone: 650-624-6900 Fax: 650-589-1501


SEARCH JOBS






Collaborations

Merck & Co., Inc.  Cardiovascular





 Company News
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Nabs Ceptaris Therapeutics, Inc. in $250 Million Buyout Deal 8/1/2013 7:14:58 AM    More...
Actelion Ltd. (ALIOF.PK) Shareholders Reject Executive Pay Plan 4/19/2013 8:18:19 AM    More...
Federal Trade Commission Slams Actelion Pharmaceuticals US, Inc. (ATLN.VX) for Withholding Samples 3/13/2013 7:31:02 AM    More...
Auxilium Pharmaceuticals (AUXL) and Actelion Pharmaceuticals US, Inc. (ATLN.VX) Announce Approval of XIAFLEX® In Canada 7/9/2012 7:31:48 AM    More...
FDA Approves Actelion Pharmaceuticals US, Inc. (ATLN.VX)'s SNDA for Second Generation VELETRI for Injection 6/29/2012 7:06:20 AM    More...
Auxilium Pharmaceuticals (AUXL) and Actelion Pharmaceuticals US, Inc. (ATLN.VX) Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico for Up to $68.5 Million 2/23/2012 7:39:59 AM    More...
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Floods FDA With Patient Death Reports 10/6/2011 7:50:51 AM    More...
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Release: Pulmonary Hypertension Association Names Dr. Ronald Oudiz Recipient of 2011 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 5/18/2011 9:03:06 AM    More...
Updated U.S. Product Labeling for Actelion Ltd. (ALIOF.PK)'s Veletri (Epoprostenol for Injection) Allows Patients to Prepare This Medication Up to a Week in Advance of Use for Pulmonary Arterial Hypertension 10/5/2010 11:43:22 AM    More...
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Pays Eur 10 Million for Option to Buy Trophos for up to Eur 195 Million 7/20/2010 12:21:56 PM    More...
123